When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. EBGLYSS for eczema: What to know about the newly FDA ... - AOL

   www.aol.com/ebglyss-eczema-know-newly-fda...

   A newly approved drug for the treatment of atopic dermatitis could make a big difference to people with moderate-to-severe eczema. Image credit: Sascha Lotz/picture alliance via Getty Images.

3. The Best Creams for Eczema in 2024 - AOL

   www.aol.com/entertainment/best-creams-eczema...

   New formulas like Restoraderm Flare-Up Relief Cream offer the best eczema-soothing repair and relief. 5. ... this eczema treatment is quick, easy, and provides relief. ... Eczema, also known as ...

4. Atopic dermatitis - Wikipedia

   en.wikipedia.org/wiki/Atopic_dermatitis

   Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. [2] Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. [2] [5] Atopic dermatitis results in itchy, red, swollen, and cracked skin. [2]

5. 7 Eczema Types: What to Know About the Symptoms, Causes ... - AOL

   www.aol.com/lifestyle/7-eczema-types-know...

   Treatment “Mild cases may be managed with frequent thick moisturizing and use of topical medications, while more severe cases can require the same in addition to phototherapy or systemic ...

6. Topical steroid - Wikipedia

   en.wikipedia.org/wiki/Topical_steroid

   Moderate steroids are used for atopic dermatitis, nummular eczema, xerotic eczema, lichen sclerosis et atrophicus of the vulva, scabies (after scabiecide) and severe dermatitis. Strong steroids are used for psoriasis , lichen planus , discoid lupus , chapped feet, lichen simplex chronicus , severe poison ivy exposure, alopecia areata , nummular ...

7. Abrocitinib - Wikipedia

   en.wikipedia.org/wiki/Abrocitinib

   In the EU, abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [9]In the US, abrocitinib is indicated for the treatment of people twelve years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics ...